PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
114.71%
Revenue growth exceeding 1.5x Insurance - Life median of 6.44%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
114.71%
Gross profit growth exceeding 1.5x Insurance - Life median of 6.44%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
286.84%
EBIT growth of 286.84% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
286.84%
Operating income growth of 286.84% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that can expand.
369.86%
Net income growth exceeding 1.5x Insurance - Life median of 11.13%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
369.52%
EPS growth of 369.52% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
370.22%
Diluted EPS growth of 370.22% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-33.59%
Negative OCF growth while Insurance - Life median is -32.69%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-33.59%
Negative FCF growth while Insurance - Life median is -32.84%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
159.62%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 16.71%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
198.25%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 18.67%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
264.37%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 16.90%. Joel Greenblatt might see a short-term competitive advantage at play.
74.87%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 36.29% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
26.57%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 13.09%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
6.05%
3Y OCF/share growth > 1.5x Insurance - Life median of 1.10%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
8.36%
Net income/share CAGR of 8.36% while Insurance - Life median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
4.47%
5Y net income/share CAGR 50-75% of Insurance - Life median. Guy Spier might question fundamental disadvantages in cost structure or growth drivers.
87.77%
3Y net income/share CAGR > 1.5x Insurance - Life median of 1.10%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
65.59%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 29.58% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
64.89%
5Y equity/share CAGR > 1.5x Insurance - Life median of 39.19%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
59.58%
3Y equity/share CAGR > 1.5x Insurance - Life median of 17.89%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.40%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
-1.03%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-1.40%
Negative BV/share change while Insurance - Life median is 0.34%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
22.55%
Slightly rising debt while Insurance - Life median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
No Data
No Data available this quarter, please select a different quarter.
-6.56%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.